Drug Delivery Systems Americas (2011) Pp
-
Upload
piyush-patel -
Category
Documents
-
view
412 -
download
3
description
Transcript of Drug Delivery Systems Americas (2011) Pp
![Page 1: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/1.jpg)
November 16th - 17th 2011, Boston, USA
Organised By
Examining latest scientific research, manufacturing and commercial opportunities
To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/ddsamericas
Anand Subramony, Principal Fellow & Head Novel Delivery Technologies & Therapeutics, Novartis
Avinash G. Thombre, Research Fellow, Pfizer
Bernhardt L. Trout, Director, Novartis-MIT Center for Continuous Manufacturing
Danchen Gao, Director of Intellectual Property Strategy, Abbott
Joseph Wong, Principal Scientist, Baxter
Kathleen L. Hefferon, Professor, University of Toronto
Lee Shorter, Director R&D Open Innovation, GlaxoSmithKline
Niren Murthy, Associate Professor, Georgia Institute of Technology
Oliver Steinbach, Senior Director, Head Bio-Molecular Engineering, Philips Corporate Technologies
Otilia Koo, Senior Research Investigator, Drug Product Science & Technology, Bristol-Myers Squibb
Peter Hoffmann, VP New Technology Development, Genzyme
Riccardo Panicucci, Head of Chemical & Pharmaceutical Profiling, Novartis
Saileta Prabhu, Scientist, Genetech
Z. Jane Li, Senior. Research Fellow, Boehringer-Ingelheim
BOOK NOW!
Drug Delivery Systems Americas 2011
Driving the Industry Forward | www.futurepharmaus.com
Media Partners
Key Speakers
CALL NOW FOR
EARLY BIRD DISCOUNTS
![Page 2: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/2.jpg)
Conference IntroductionDrug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
Dear Colleague,
Worth$93.60bnin20091,drugdeliverytechnologyandsystemsisone
ofthefastestgrowingmarketsinthepharmaceuticalandbiotechnology
sectorswithalmost50%oftherevenuegeneratedfromNorthAmerica2.
Thissectorisexpectedtomaintaindoubledigitgrowthinthecomingyears
whichwilldependonnewandinnovativedevelopmentsindrugdelivery
technologythatofferimprovedclinicaladvantages,patientcomfort,
convenienceandcompliance.
DrugDeliverySystemsAmericas2011-buildingonthesuccessofour
previoussixdrugdeliveryconferenceswillbringtogetherindustryexperts
fromaroundtheworldtodiscussthecrucialissuesandcurrenttrends
indrugdeliverysystems.Thistwodayeventwillfocusonvariousdrug
formulations,deliveryoflipids,proteinsandpeptidesadditionallyexploring
drugdeliverycommercialaspects,partneringandout-sourcing,key
regulatoryandlegalissues.
Attendance at this conference will enable you to:
•Overcomechallengesandopportunitiesinthedeliveryofsmallmolecules
•Gaininsightaboutproteinandpeptidedrugdeliverystrategiesforproduct
lifecyclemanagement
•Exploreinnovationsingenericdevelopmentofdrugdeliverysystems
•Discussaboutenhancingthebioavailabilityofpoorlysolubledrugs
•Learnimpactonproductlifecycles:controlled-releasetechnologies
•Evaluateniosomesaseffectivetransdermaldrugdeliverysystems
•Discoveradvancesinoraltransmucosaldrugdelivery
•Stayaheadbylearninglatestonbiologicsdeliverysystems
•Identifydifferentstrategiesinmanagingadrugdeliveryalliance
•ExaminePTD–DRBDsiRNADelivery
•Obtainlatestinformationonultrasonicdrugdelivery
•Createpatientcentereddrugdeliveryproduct
•Findoutinformationonregulationsandcurrentpracticesnasaldrugproducts
•ReviewadvancedtechnologicalandregulatorydevelopmentsonQbD/PAT
inPharmaceuticaldevelopment
•Preventaggregationinmanufacturingandformulationofproteinand
peptidetherapeutics
•Obtainthelatestmarketanalysis,andmeetmanufacturersshowcasing
theirleadingproducts
Ilookforwardtomeetingyouattheconference
Bestregards
Sonia Tomar Conference Producer
Poster PresentationAt a busy conference it is hard to make sure everyone who shares your interests knows what you are doing. Maximise your time at Visiongain’s Biosimilars and Follow-On Biologics Americas meeting by sharing your results in a poster presentation. With a plethora of key decision makers, take advantage of this senior networking opportunity.
Please send your 200 word abstract, in English, to: [email protected] for approval. The deadline for submissions is Friday, November 4th, 2011. Please include contact details for the corresponding author(s).
Academic institutions will not be charged a fee if booked as full-price delegates. Posters submitted by pharmaceutical and biotechnology firms will be charged a fee of £199 (USD $319*).
Posters submitted by service providers / vendors are welcome and will be subject to evaluation. Upon approval a fee of £500 (USD $801*) will apply. Two delegates from your organisation must be booked at full price to present a poster.
Please note that all posters will be displayed at the discretion of Visiongain Ltd and are subject to approval. Due to limited space, please register your interest early.
Who should attend this conference?VPs, Directors, Heads, Managers of:• Pharmaceutical Development• Drug Delivery• Delivery Device Development• Product Development• Analytical Chemistry• Pre-formulation• Project Management• Technology Development• Drug Delivery Partnering• Out-sourcing• In-Licensing• Technology Assessment• Lifecycle management• Strategic Planning and Development• Formulation/Stability• Business Development• Licensing• Commercial Development• Patents• Lifecycle Management• Strategic Planning and Development• Financial Analyst• Pharmaceutical and Analytical R&D• Testing• New Product Planning• New Technology Evaluation• Marketing• Brand Management• Product Management• Sales• Regulatory AffairsOthers: • Intellectual Property Attorneys• Venture Capitalists• Medical Device Companies• Analysts/Investment Banks• CROs• Contract Sales Organisations• Universities and Government Research• Testing and Manufacturing Equipment • Packaging Companies
1visiongain’sDrugDeliverytechnologies:Commercialprospects2010-20252MarketsandMarkets:Top10DrugDeliveryTechnologiesMarkettobeUS$156Billionby2015
*USDpriceisestimateonly
![Page 3: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/3.jpg)
Day 1Drug Delivery Systems Americas
Wednesday November 16th 2011
09:00 Registration and refreshments
09:30 Opening address from the chair
09:40 The magic bullets of the shots heard round the world targeted macromolecule delivery
•Obtainoverviewoftheoptiontodeliverbiologicstotarget •Stimulateuseadvanceddrugdeliveryformulationfortargeting •Enablemacromoleculestargetingtotreat •Identifystateofthearttargetingdeliveryoptions
Peter Hoffmann VPNewTechnologyDevelopmentGenzyme Pharmaceuticals
10:20 Emerging drug delivery technologies towards patient centric therapy
•Deliveryofhighvolumebiologics/antibodies: •Patchpumpsdevicesasanemergingalternativetosubcutaneous
injectionsforthedeliveryofbiologics •Useofmechanicalandelectromechanicalsystems •Creatingpatientcentricdrugdeliverytoolsviauserstudies •Microneedlesandthetrandermalinterface •Programmabledrugdeliverymethods
Anand Subramony PrincipalFellowandHeadNovartis
11:00 Morning refreshments
11:20 Overcome challenges and opportunities in the delivery of small molecules
•Fundamentalsofdeliveryofsmallmolecules •Controlledreleaseindeliveryofproteinsandnucleicacids •Analysingintestinalsolubilityandpermeabilityandparticlesizeto
overcomeratelimitedabsorption
Z. Jane Li SeniorResearchFellowBoehringer-Ingelheim
12:00 Development and administration of intravenous nanosuspension
•Therehasbeengrowinginterestinnanoparticlesasanapproachtoformulatepoorlysolubledrugs
•Thispresentationprovidesaninsightintovariouschallengesassociatedwithdevelopingandadministratingintravenousnanosuspensionincluding:
•Aformulationapproachofstabilizingnanosuspension •Particlesizeandnanosuspensionsterilityconsiderations •Pre-clinicaldispositionofananosuspensionfollowingIVadministration •Infusionratesfornanosuspension
Joseph Wong PrincipalScientistBaxter
12:40 Networking lunch
13:40 Life cycle management through drug delivery technologies
•Challengesandopportunitiesinlifecyclemanagement •Productenhancementusingdrugdelivery •Platformcontrolledreleasetechnologies •Casestudiesandlessonslearned
Avinash G. Thombre ResearchFellowPfizer
14:20 Life-cycle management: development and manufacturing process considerations for fixed-dose combination drug products
•Materialpowderandmechanicalpropertiesconsiderationsthatimpacttheprocessibilityandquantityoffixed-dosecombinationproducts
•Technologiestomonitorprocessandproductquality,aswellastomanagerisks
•Controlsystemsthatcanimprovescale-upandmanufacturing
Otilia Koo SeniorResearchInvestigator,DrugProductScience&TechnologyBristol-Myers Squibb
15:00 Afternoon Refreshments
15:20 The mucosal response to plant-derived biopharmaceuticals
•Biopharmaceuticalscanbeproducedquicklyandinexpensivelyinplants
•Consumptionofvaccinesproteinsviaedibleplanttissueshasbeendemonstratedtoeffectivelyelicitamucosalimmuneresponse
•Plantshaveadvantagesasbioreactorsbecauseunlikebacterialsystems,theypossesspost-translationalmachinery,andunlikemammaliancellculturesystems,theyarefreefrominfectiouscontaminants
•Plant-derivedbiopharmaceuticalshaveenormouspotentialforassistingvaccinationprogramsindevelopingcountries,forthepreventionofglobalpandemics/bioterrorism,andforapplicationsinpersonalizedmedicine
•Anumberofplantderivedbiopharmaceuticalshavecompletedclinicaltrialsandhavenowenteredtheglobalmarketplace
Kathleen L. Hefferon ProfessorUniversity of Toronto
16:00 Addressing delivery of antibodies across the blood-brain barrier (BBB)
•Overviewofthetransportbarriersforantibodiesinthebrain
•DispositionofantibodiesintheCNS
•Leveragingreceptor-mediatedtranscytosisforCNSdelivery
Saileta Prabhu ScientistGenetech
16:40 Closing remarks from the chair
16:50 Networking Drinks Take your discussions further and build new
relationships in a relaxed and informal setting.
Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011
NEW
SLETTER
Pharma Business DailyEach issue of Pharma Business Daily newsletter focuses on latest breaking stories in your market. Delivered directly to your Inbox or available through the website, all the industry news is available to you all the time. When you want the news its there for you - it really is that simple. Over 25+ stories everyday as they happen. Never again will any of your colleagues be aware of news that you aren’t. Plus exclusive features from visiongain conferences and in-depth analysis from visiongain analysts will be available to you thanks to your subscription to PharmaBusinessDaily. This information is not available anywhere else.Call +44 (0)207 336 6100 or visit www.visiongain.com to sign up.
![Page 4: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/4.jpg)
Day 2Drug Delivery Systems AmericasThursday November 17th 2011
09:00 Registration and refreshments
09:30 Opening address from the chair
09:40 New materials for drug delivery and molecular imaging
•Overviewonnewmaterialsfordrugdelivery
•Autocatalyticdrugdeliveryvehincles
•Polyketals:anewbiomaterialfordrugdelivery
•OralsiRNAdeliveryvehicles
Niren Murthy AssociateProfessorGeorgia Institute of Technology
10:20 IMAG(IN)E global - release local – Image-guided ultra sound-triggered drug delivery
•Medicalimagingtechnologiesarebecominganintegralpartoftherapeuticinterventions
•Thedevelopmentofultrasoundtechniquesthatcouldnon-invasivelytriggerthedeliveryofalsoverynewdrugformatssuchasRNAitherapeuticsatatargetedlocationopensupexcitingpossibilitiesforadvancingpersonalizedmedicine
•Akeysuccessfactorfortheeffectivetranslationofnewdrugdeliveryconceptsintoclinicalpracticearepartnershipswithleadingacademic,medicalinstitutionsandindustrialpartners
•Philips’image-guidedultrasound-mediateddrugdeliveryplatformoffersresearchersauniqueapproachtoinvestigatingthedeliveryofvarioustherapeuticmoleculesandcapitalizesuponPhilips’existingexpertiseinmedicalimagingtechnologiesfordiagnosis,therapyplanningandminimally-invasivemedicalprocedures
•WeshowadvancesintemperaturesensitiveliposomeswithincorporateddrugsandMRI-imaginglabelsaswellaspressure-sensitivemicrobubbleswithspecificultrasound-imaginganddrugreleasecharacteristicsforthelocaldeliveryofsmallmolecule-andnucleic-acidbasedtherapeuticsincludingsiRNA
Oliver Steinbach SeniorDirector,HeadBio-MolecularEngineeringPhilips Corporate Technologies
11:00 Morning refreshments
11:20 Sponsor Spotlight Session
Takethisuniqueopportunitytobeapartoftheconferencetheme,network,shareideasandprovideanoverviewofyourproduct/servicestotheaudience.Formoreinformationpleasecontactdamian.gorman@visiongainglobal.com
12:00 Presentation to be announced
Riccardo Panicucci HeadofChemical&PharmaceuticalProfilingNovartis
12:40 Networking lunch
13:40 Prevent aggregation in manufacturing and formula-tion of protein and peptide therapeutics
•Techniquestopredictaggregationpropensity
•Newapproachestopreventingaggregation
•Astrategyfordevelopabilityandmanufacturabilityearlyon
•Waystodesignmoleculesforstability
Bernhardt L. Trout Director, Novartis-MIT Center for Continuous Manufacturing Professor,DepartmentofChemicalEngineering, Massachusetts Institute of Technology
14:10 Finding synergy in drug delivery through strategic outsourcing
•Thevalueofstrategicoutsourcing:decisiondrivers
•Fromtransactionaltostrategic
•Strategicoutsourcing:whatliesahead
Danchen Gao DirectorofIntellectualPropertyStrategyAbbott
15:00 Afternoon refreshments
15:20 Open Innovation in preclinical development at GSK pharmaceuticals
•Whatisopeninnovation?
•WhyisGSKusingopeninnovationwithintheplatformtechnologyandSciencegroup?
•ProcessGSKPTSisfollowingforopeninnovation
•Examplesofsuccessfulopeninnovationcollaborations
•Howwillsuccessofopeninnovationbemeasured?
Lee Shorter DirectorR&DOpenInnovationGlaxoSmithKline
16:00 Patent and other Intellectual property rights in drug delivery
•Advancementsindrugdeliverytechnology
•Patentingthetechnologicaladvancements
•Issuesaroundmanufacturingprocesspatents
•Intellectualpropertyprotection,suchastradesecrets,copyrights,andtrademarks
16:40 Chair’s closing remarks
16:50 End of Conference
![Page 5: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/5.jpg)
PartnersDrug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
Media Partners:
PharmiWeb.comistheleadingindustry-sponsoredportalforthepharmaceuticalsector.Supported
bymostoftheleadingpharmaceuticalcorporations,PharmiWeb.comprovidesdynamicreal-timenews,features,eventslistingsandinternationaljobstoindustryprofessionalsacrossEuropeandtheUS.For further information please email: [email protected]
BIOTECHNOLOGYEUROPEisownedbyBIOTECHNOLOGYWORLD.Itisbasedandlocated
inWarsaw,Poland.BiotechnologyWorldwasfoundedin2007toprovidetheworld’sbiotechandpharmainformationandmarkettomakeituniversallyaccessibleandusefulforscientificandbusinessprocesses.ItsfirststeptofulfillingthatmissionwasbuildingtheBIOTECHNOLOGYEUROPEplatformthatwillallowaquickspreadofinformationindifferentchannels.BIOTECHNOLOGYEUROPEofferscompaniescompletedinternetpublicrelations,publicationandmarketingsolutions.OneofthemainsgoalsofBIOTECHNOLOGYEUROPEistointegratetheBiotechandPharmaSectorinEuropetoglobalbiotechnology,pharmaceuticalandlifescienceactivities.For further information please visit www.biotechnology-europe.com
InPharmistheonlineplatformforexclusivepharmaceuticalnews,comment,contracts,services,
jobsandeventsandishometoInPharmjobs.com,PharmafileandPharmafocus.For further information please visit: www.inpharm.com
FuturePharmaceuticalshasforgedpowerfulrelationshipswithkeyindustryleaderstoprovide
aplatformforsuccessfulbrandrecognition,andforseniordecision-makerstohavethemeanstoprocureandplanimplementationstrategiesbasedonthetopicscovered.Positionedtobeanauthoritativeresourcewithintoppharmacompaniesaswellassmall,specialty,andbiotech,FuturePharmaceuticalsmagazineisgearedtocreateadeeppenetrationintoahighlytargetedandresponsiveaudience,bridgingthegapbetweentheindustries’topissuesandthesolutionstop-tiervendorscanprovide.For further information please visit: www.futurepharmaus.com
Driving the Industry Forward | www.futurepharmaus.com
Sponsorship and exhibition opportunities:
This event offers a unique opportunity to meet and do business
with some of the key players in the pharmaceutical and biotech
industries. If you have a service or product to promote, you can
do so at this event by:
• Hosting a networking drinks reception
• Taking an exhibition space at the conference
• Advertising in the delegate documentation pack
• Providing branded bags, pens, gifts, etc.
If you would like more information on the range of
sponsorship or exhibition possibilities for visiongain's
Drug Delivery Systems Americas Conference,
please contact us.
Damian Gorman, +44 (0)20 7549 9934
About visiongain:
Visiongain is a specialist business information company focused on
providing cutting edge products and services across the Pharmaceutical/
Biotech, Telecommunications, Defence and Finance sectors, which
include reports, conferences, online daily news and offline news
analysis and bespoke consultancy. With a commitment to innovation
and excellence, visiongain offers flexible solutions to meet our clients’
business intelligence needs, providing the right information at the
right time to facilitate the commercial decision-making process. Our
pharmaceutical products include Pharma Business Daily, the leading
daily email newsletter for the pharmaceutical, biotech and healthcare
industries, and a range of independent, high-quality, in-depth reports
covering focused and topical areas of concern. Our pharmaceutical
conferences address the hottest commercial, regulatory and technical
topics and provide an ideal forum for debate and networking for
pharmaceutical professionals from around the world.
For further information, please visit: www.visiongain.com
![Page 6: Drug Delivery Systems Americas (2011) Pp](https://reader030.fdocuments.in/reader030/viewer/2022020110/55793323d8b42ad6678b49ef/html5/thumbnails/6.jpg)
How to bookEmail:[email protected]:http://www.visiongain.com/ddsamericas
UK Office:Tel: +44(0)207549 9961Fax:+44(0)2075499932 VisiongainLtd230CityRoadLondonEC1V2QYUK
General informationVenue:TBA,Boston,USA
Payment terms:Visiongainrequirethefullamounttobepaidbeforetheconference.VisiongainLtdmayrefuseentrytodelegateswhohavenotpaidtheirinvoiceinfull.Acreditcardguaranteemayberequestedifpaymenthasnotbeenreceivedinfullbeforetheevent.VisiongainLtdreservestherighttochargeinterestonunpaidinvoices.
Substitutions/name changes or cancellations: Thereisa50%liabilityonallbookingsoncemade,whetherbypost,fax,emailorweb.Thereisanorefundpolicyforcancellationsreceivedonorafteronemonthbeforethestartoftheevent.Shouldyoudecidetocancelafterthisdate,thefullinvoicemustbepaid.Conferencenoteswillthenbesenttoyou.Unfortunately,weareunabletotransferplacesbetweenconferences.However,ifyoucannotattendtheconference,youmaymakeasubstitution/namechangeatanytime,aslongasweareinformedinwritingbyemail,faxorpost.Namechangesandsubstitutions must be from the same company or organisation and are not transferable betweencountries.Pleasenotethatdiscounteddelegatesplacesatavisiongaineventarenonrefundable.
Invoice alterations:Therewillbeanadministrationchargeof£50foranychangestoaninvoice,excluding substitutions/name changes, requested by the customer. This will be charged to thecustomerbycreditcardpriortothechangesbeingmade.
Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executivebriefingcontent,timing,speakersorvenuewithoutnotice.TheeventmaybepostponedorcancelledduetounforeseeneventsbeyondthecontrolofvisiongainLtd.Ifsuchasituationarises,wewilltrytorescheduletheevent.However,visiongainLtdcannotbeheldresponsibleforanycost,damageorexpenses,whichmaybeincurredbythecustomerasaconsequenceoftheeventbeingpostponedorcancelled.Wethereforestronglyadviseallourconferenceclientstotakeoutinsurancetocoverthecostoftheregistration,travelandexpenses.
Data Protection: Visiongain Ltd gathers and manages data in accordance with the DataProtectionAct1988.YourpersonalinformationcontainedinthisformmaybeusedtoupdateyouonvisiongainLtdproductsandservicesviapost,telephone,faxoremail,unlessyoustateotherwise.Wemayalsoshareyourdatawithexternalcompaniesofferingcomplementaryproductsorservices.Ifyouwishforyourdetailstobeamended,suppressedornotpassedontoanyexternalthirdparty,pleasesendyourrequesttotheDatabaseManager,visiongainLtd,BSGHouse,226-236CityRoad,London,EC1V2QY.Alternatively,youcanvisitourwebsiteatwww.visiongain.comandamendyourdetails.Pleaseallowapproximately30daysforyourremovalorupdaterequesttobeappliedtoourdatabase.Followingyourremovalorupdaterequest,youmayreceiveadditionalpiecesofcommunicationfromvisiongainLtdduringthetransitionalperiod,whilstthechangesarecomingintoeffect.
Fee: Theconferencefeeincludeslunch,refreshmentsandconferencepapersprovidedontheday.This feedoesnot include travel, hotel accommodation, transfersor insurance, (whichwe stronglyrecommendyouobtain).
VAT: VATwillbechargedatthelocalrateoneachconference.DelegatesmaybeabletorecoverVATincurredbycontactingEurocashCorporationplc+44(0)1273325000,eurocash@eurocashvat.com.Eurocashspecialiseinrecoveringcross-borderVAT.
How we will contact you: VisiongainLtd’spreferredmethodofcommunicationisbyemailandphone.Pleaseensurethatyoucompletetheregistrationforminfullsothatwecancontactyou.
Unable to attendObviouslynothingcomparestobeingtherebutyouneednotmissout.Simplyticktheboxandsendwithyourpayment.YouwillreceivespeakertalksinPDFstwoweeksaftertheevent.
Yes, please send me speaker talks Price£550 VAT:£110 Total:£660
Office use only
Conf.codePP
Standard Prices
Conference only Fee: £1299 (USD* 2081)
Number of bookings: Total cost:
*USDpriceisestimateonly
Promotional Literature DistributionDistribution of your company’s promotional literature to all conference attendees
Fee: £999 VAT: £199.80 Total: £1198.80
Details
Forename: Surname:
JobTitle: Company:
MainSwitchboardNumber:
Address:
Country: Postcode:
Phone: Fax:
Email:
Signature:
IconfirmthatIhavereadandagreetothetermsandconditionsofbooking
Methods of paymentPaymentmustbemadeinsterling
By Mail: Completeandreturnyoursignedregistrationformtogetherwithyourchequepayable
toVisiongainLtdandsendto:visiongainLtd,BSGHouse,226-236CityRoad,London,EC1V2QY,UK
By Fax: Completeandfaxyoursignedregistrationformwithyourcreditcarddetails
to+44(0)2075499932
By Phone:Calluson+44(0)2073366100withyourcreditcarddetails
By Credit Card:Fillinyourcarddetailsbelowandfaxbackto+44(0)2075499932
By Bank Transfer:
VisiongainLtd A/C:visiongainLtd
BarclaysBank SortCode:20-71-64
PiccadillyBranch AccountNo:60387118
48RegentStreet SwiftCode:BARCGB22
LondonW1B5RA,UK IBAN:GB80BARC20716460387118
Please debit my credit card:
Access MasterCard Visa AmericanExpress
Cardnumber:
ExpiryDate:
Securitynumber(last3digitsonbackofcreditcard):
Signature:
Cardholder’sname:
News updatesPleasetickifyoudonotwanttoreceiveemailnewsupdatesinthefuture
Registration FormDrug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
www.visiongain.com/ddsamericas
Drug Delivery Systems AmericasNovember 16th - 17th 2011
Boston, USA